These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The epidemiology of HIV coreceptor tropism. Hoffmann C Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718 [TBL] [Abstract][Full Text] [Related]
11. Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists. Raymond S; Delobel P; Izopet J J Antimicrob Chemother; 2010 Sep; 65(9):2056-7; author reply 2058-9. PubMed ID: 20554569 [No Abstract] [Full Text] [Related]
12. Antiretrovirals in the pipeline: anticipated updates. Laurence J AIDS Read; 2005 Nov; 15(11):577-8. PubMed ID: 16329178 [No Abstract] [Full Text] [Related]
13. [CCR5 inhibitors. A new point of attack for HIV infection]. Heinzl S Med Monatsschr Pharm; 2007 Dec; 30(12):434-8; quiz 439-40. PubMed ID: 18196845 [No Abstract] [Full Text] [Related]
14. Anti-HIV agents. What makes a viral load blip? TreatmentUpdate; 2008 Jan; 20(1):4. PubMed ID: 18320693 [No Abstract] [Full Text] [Related]
16. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications]. Azevedo-Pereira JM; Santos-Costa Q Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693 [TBL] [Abstract][Full Text] [Related]
17. [CCR5 antagonists: a new class of antiretrovirals]. Peytavin G; Calvez V; Katlama C Therapie; 2009; 64(1):9-16. PubMed ID: 19463248 [TBL] [Abstract][Full Text] [Related]